No connection

Search Results

EHAB vs PSNL

EHAB
Enhabit, Inc.
BEARISH
Price
$13.74
Market Cap
$703.8M
Sector
Healthcare
AI Confidence
85%
PSNL
Personalis, Inc.
BEARISH
Price
$6.73
Market Cap
$704.5M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
EHAB
--
PSNL
--
Forward P/E
EHAB
22.12
PSNL
-7.12
P/B Ratio
EHAB
1.31
PSNL
2.64
P/S Ratio
EHAB
0.66
PSNL
10.11
EV/EBITDA
EHAB
13.71
PSNL
-6.51

Profitability

Gross Margin
EHAB
49.04%
PSNL
22.65%
Operating Margin
EHAB
5.33%
PSNL
-145.67%
Profit Margin
EHAB
-0.43%
PSNL
-116.69%
ROE
EHAB
-0.46%
PSNL
-35.02%
ROA
EHAB
3.33%
PSNL
-18.21%

Growth

Revenue Growth
EHAB
4.7%
PSNL
3.2%
Earnings Growth
EHAB
--
PSNL
--

Financial Health

Debt/Equity
EHAB
0.89
PSNL
0.17
Current Ratio
EHAB
1.63
PSNL
6.76
Quick Ratio
EHAB
1.49
PSNL
6.46

Dividends

Dividend Yield
EHAB
--
PSNL
--
Payout Ratio
EHAB
0.0%
PSNL
0.0%

AI Verdict

EHAB BEARISH

EHAB exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational deterioration. While the stock has seen a significant 1-year price surge (+78.4%), this momentum is disconnected from core profitability, as evidenced by a negative profit margin (-0.43%) and negative ROE (-0.46%). The lack of a Graham Number and the absence of an Altman Z-Score, combined with bearish insider selling, suggest a speculative valuation. The recent price action likely reflects merger speculation mentioned in SEC filings rather than organic growth.

Strengths
Strong 1-year price momentum (+78.4%)
Low Price-to-Sales ratio (0.66)
Healthy liquidity ratios (Current Ratio 1.63, Quick Ratio 1.49)
Risks
Critical financial health failure (Piotroski F-Score 2/9)
Negative net profit margins and negative Return on Equity
Stagnant revenue growth (4.70% YoY)
PSNL BEARISH

PSNL exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health and operational deterioration. Despite a 'Strong Buy' analyst consensus and a high current ratio, the company suffers from massive negative profit margins (-116.69%) and stagnant revenue growth (3.20%). The disconnect between analyst price targets and the deterministic data suggests a speculative valuation not supported by current earnings or growth trajectories. Insider selling by the CEO and COO further reinforces a bearish outlook.

Strengths
Strong liquidity position with a Current Ratio of 6.76
Low leverage with a Debt/Equity ratio of 0.17
Positive analyst sentiment with a target price of $11.29
Risks
Critical financial health (Piotroski F-Score 1/9)
Severe lack of profitability with operating margins at -145.67%
Stagnant revenue growth (3.20% YoY) for a diagnostics growth company

Compare Another Pair

EHAB vs PSNL: Head-to-Head Comparison

This page compares Enhabit, Inc. (EHAB) and Personalis, Inc. (PSNL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile